Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
6.83
+0.15 (2.25%)
At close: Apr 24, 2024, 4:00 PM
6.89
+0.06 (0.88%)
After-hours: Apr 24, 2024, 7:49 PM EDT
Avid Bioservices Market Cap
Avid Bioservices has a market cap or net worth of $431.92 million as of April 25, 2024. Its market cap has decreased by -63.69% in one year.
Market Cap
431.92M
Enterprise Value
596.12M
1-Year Change
-63.69%
Ranking
Category
Stock Price
$6.83
Market Cap Chart
Since December 1, 1998, Avid Bioservices's market cap has increased from $64.40M to $431.92M, an increase of 570.69%. That is a compound annual growth rate of 7.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 433.60M | 2.65% |
Apr 23, 2024 | 422.40M | 4.19% |
Apr 22, 2024 | 405.40M | 0.32% |
Apr 19, 2024 | 404.10M | -1.99% |
Apr 18, 2024 | 412.30M | -2.83% |
Apr 17, 2024 | 424.30M | -7.46% |
Apr 16, 2024 | 458.50M | 6.63% |
Apr 15, 2024 | 430.00M | 0.89% |
Apr 12, 2024 | 426.20M | -2.34% |
Apr 11, 2024 | 436.40M | - |
Apr 10, 2024 | 436.40M | -4.02% |
Apr 9, 2024 | 454.70M | 8.29% |
Apr 8, 2024 | 419.90M | 4.74% |
Apr 5, 2024 | 400.90M | - |
Apr 4, 2024 | 400.90M | -3.79% |
Apr 3, 2024 | 416.70M | 3.27% |
Apr 2, 2024 | 403.50M | -0.62% |
Apr 1, 2024 | 406.00M | -4.18% |
Mar 28, 2024 | 423.70M | -4.01% |
Mar 27, 2024 | 441.40M | 2.79% |
Mar 26, 2024 | 429.40M | -0.58% |
Mar 25, 2024 | 431.90M | 1.48% |
Mar 22, 2024 | 425.60M | -2.05% |
Mar 21, 2024 | 434.50M | -3.36% |
Mar 20, 2024 | 449.60M | 1.28% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Pacific Biosciences of California | 415.33M |
Larimar Therapeutics | 414.70M |
Voyager Therapeutics | 412.96M |
biote | 412.53M |
Lexeo Therapeutics | 410.86M |
IGM Biosciences | 408.80M |
LENZ Therapeutics | 405.47M |
Tourmaline Bio | 403.80M |